Medication info
Romantine 20 mg (Memantine Hydrochloride)

Romantine 20 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202401709 · Approved 2024.07.11 · Insurance code 693202590

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg each week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily for 7 days. Week 3 (Days 15–21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg each week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily for 7 days. Week 3 (Days 15–21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients who are hypersensitive to its components or have severe liver or kidney dysfunction. Patients with epilepsy or a history of seizures, and those taking other drugs that act on NMDA receptors, should use this drug with caution due to an increased risk of side effects. Particular caution is also required for patients with factors that cause changes in the pH of the urinary tract or those with recent heart disease. When taking this drug, it is important to monitor for side effects such as dizziness, headache, constipation, drowsiness, and hypertension. There may be interactions with other medications, so it is advisable to consult a physician or pharmacist, especially when taking NMDA antagonists, antipsychotic drugs, muscle relaxants, anticoagulants, etc. If pregnant or breastfeeding, administration should be done cautiously considering the effects on the fetus or newborn, and it is recommended to discontinue breastfeeding while taking this medication. Safety and efficacy have not been established in pediatric and adolescent patients under 18 years of age, hence it is advisable not to use this drug in this population. In case of overdose, central nervous system symptoms such as confusion, drowsiness, hallucinations, and seizures may occur, so immediate medical attention is required for appropriate treatment. This drug may impair the patient's reaction speed, so special caution is advised when driving or operating machinery. When storing, keep in a safe place out of reach of children, and do not transfer to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucinations
Show 32 more
  • psychotic reactions
  • dizziness
  • balance disorder
  • gait abnormality
  • seizures
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • sense of fatigue
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucinations
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air and moisture exposure. The suitable storage temperature is room temperature between 1 degree and 30 degrees Celsius. Avoid storing in places that are too hot or too cold.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.